Hims

Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.

Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like a commentary on the wealthy’s access to better healthcare.

Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in…

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth company less than…

Feb. 25, 2025 5:00 AM ETZoom Communications Inc. (ZM) Stock, CLF Stock, HIMS Stock, EVER Stock, BTC-USD CryptoMSTR, RIOT, MARA, CLSK, COIN, BTBT, BTDRBy: Niloofer Shaikh, SA News Editor Adam…

Telehealth and wellness platform Hims & Hers on Monday offered a revenue outlook for the year ahead that topped Wall Street’s expectations, but shares fell hard in after-hours trading, in…